A wound care system impregnated with manuka honey has passed the FDA’s 510(k) approval process. The concept from Derma Sciences has passed approval in several iterations prior, but the new formulation comes in gel form (no, the tube is not shaped like a bear.) A cursory PubMed and Medical Lit search does in fact show a developing evidence base for the use of honey in wound care management for its purported anti-microbial and immune activating properties.
From the press release:
This latest MEDIHONEY line extension is dispensed from a tube and is comprised of Active Manuka (Leptospermum) honey blended with natural-based gelling agents. This is the fourth product in the expanding MEDIHONEY franchise, and will be launched into the market by the Company’s 20-person U.S. sales force at the major annual wound conferences this spring.
Full press release: Derma Sciences Receives FDA Clearance for MEDIHONEY® Gel
Product page: MediHoney…
Flashback: Bacterial Resistance? Medihoney to the Rescue!